HCSC Contract Renewal

Cirata PLC
30 September 2024
 

30 September 2024

 

Cirata plc

("Cirata" or the "Company")

HCSC Contract Renewal

 

Cirata plc (LSE: CRTA) is pleased to announce that the Health Care Service Corporation (HCSC) has renewed its existing contract for Cirata's Fusion product for a period of 12 months. The total consideration for the term is $983,010. The use case supports HCSC disaster recovery for on-premises Hadoop data moving to Microsoft Azure cloud. Fusion is a data migration product.

 

 

This announcement contains inside information under the UK Market Abuse Regulation. The person responsible for arranging the release of this announcement on behalf of Cirata plc is Larry Webster, Company Secretary.

 

 

For further information, please contact: 

 

Cirata

+1 (925) 380 1728

Stephen Kelly, Chief Executive Officer


Ijoma Maluza, Chief Financial Officer


Daniel Hayes, Investor Relations




FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali




Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Ben Good / Sarah Wong




Panmure Liberum (Joint Broker)

+44 (0)20 3100 2000

Max Jones / John More


 

 

About Cirata

 

Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Cirata (CRTA)
UK 100

Latest directors dealings